The Mechanism of Kelulut Honey in Reversing Metabolic Changes in Rats Fed with High-Carbohydrate High-Fat Diet.
Khairun-Nisa HashimKok-Yong ChinFairus AhmadPublished in: Molecules (Basel, Switzerland) (2023)
Metabolic syndrome (MetS) is composed of central obesity, hyperglycemia, dyslipidemia and hypertension that increase an individual's tendency to develop type 2 diabetes mellitus and cardiovascular diseases. Kelulut honey (KH) produced by stingless bee species has a rich phenolic profile. Recent studies have demonstrated that KH could suppress components of MetS, but its mechanisms of action are unknown. A total of 18 male Wistar rats were randomly divided into control rats (C group) ( n = 6), MetS rats fed with a high carbohydrate high fat (HCHF) diet (HCHF group) ( n = 6), and MetS rats fed with HCHF diet and treated with KH (HCHF + KH group) ( n = 6). The HCHF + KH group received 1.0 g/kg/day KH via oral gavage from week 9 to 16 after HCHF diet initiation. Compared to the C group, the MetS group experienced a significant increase in body weight, body mass index, systolic (SBP) and diastolic blood pressure (DBP), serum triglyceride (TG) and leptin, as well as the area and perimeter of adipocyte cells at the end of the study. The MetS group also experienced a significant decrease in serum HDL levels versus the C group. KH supplementation reversed the changes in serum TG, HDL, leptin, adiponectin and corticosterone levels, SBP, DBP, as well as adipose tissue 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) level, area and perimeter at the end of the study. In addition, histological observations also showed that KH administration reduced fat deposition within hepatocytes, and prevented deterioration of pancreatic islet and renal glomerulus. In conclusion, KH is effective in preventing MetS by suppressing leptin, corticosterone and 11βHSD1 levels while elevating adiponectin levels.
Keyphrases
- adipose tissue
- blood pressure
- insulin resistance
- metabolic syndrome
- high fat diet
- physical activity
- body mass index
- cardiovascular disease
- type diabetes
- heart failure
- body weight
- fatty acid
- clinical trial
- heart rate
- cell proliferation
- skeletal muscle
- uric acid
- cardiovascular risk factors
- cell death
- cell cycle arrest
- cardiovascular events